USA

The US pharmaceutical market is one of the key focus areas for Marksans Pharma. The company has achieved the required approvals from the US FDA and has actively started exporting formulation to US.

Our target is the technology driven niche liquid gel market which is tapped by select players, thus providing differentiation. Marksans offers innovative product offerings through exclusive tie-ups, supply and marketing arrangements.

We are focused towards formulation development and have a strong back up in terms of R&D and aggressive marketing plans.